Prostate cancer is the most common malignant tumor of the genitourinary system in men. Statistics show that this disease is in second place among oncological pathologies that are the cause of death of men over 50 years old.⠀
The incidence of prostate cancer is 120 cases per 100,000 men of all age groups. Medical statistics show that one man out of seven will be diagnosed with prostate cancer during his lifetime and one out of thirty-eight men will die from prostate cancer.
Unfortunately, the typical symptoms of this disease appear only in the later stages. The patient is not bothered by any symptoms. Most men come to see a doctor even when the tumor is in a neglected state, treatment takes more effort and time, and the prognosis is getting worse.
this regard, the need for early diagnosis of prostate cancer is obvious.
The only way to detect a malignant prostate tumor in time is regular screening examination. Prostate cancer diagnosis includes the determination of a specific cancer marker in the blood – PSA, with the increase of which a prostate biopsy is performed.
MSH “Neftyanik” conducts a comprehensive examination of men who have a suspicion of the disease, as well as an annual screening of all men starting from the age of 45.
Timely qualitative diagnosis of prostate cancer is an early effective treatment and a more favorable prognosis.
⠀- Prostate Specific antigen (PSA) study;
⠀- Fusion prostate biopsy (MRI-controlled biopsy);
⠀- Prostate cancer.
Simultaneously with conventional ultrasound, Dopplerography and duplex scanning can be applied – these ultrasound techniques allow you to assess the state of blood flow in the organ itself and in the tumor.
Do not wait for the disease to manifest itself with symptoms, take care of yourself in advance!